Kaitlin Elizabeth Kilian, NP

Kaitlin Kilian practices at Stanford Health Care Tri-Valley in Pleasanton, California, part of Stanford University.

Kaitlin Kilian's NPI, 1558716704, was assigned on April 25, 2016. Kaitlin Kilian holds California license 95003687.

Kaitlin Kilian's primary practice is Stanford Health Care Tri-Valley, at 5555 West Las Positas Boulevard, Pleasanton, CA 94588 in Alameda County. The practice phone is (925) 847-3000.

Kaitlin Kilian's primary practice is Stanford Health Care Tri-Valley in Pleasanton, California, part of Stanford University. Kaitlin Kilian is also affiliated with Stanford Hospital at 300 Pasteur Drive. The medical group on file is Stanford Health Care. Dmand AI also links Kaitlin Kilian to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Kaitlin Kilian practices, 2 sites in all. Vendor and product names are available with a free account.

Nurse practitioner is Kaitlin Kilian's primary specialty in the NPI Registry, under taxonomy code 363L00000X. Kaitlin Kilian is licensed in California.

Dmand AI lists chronic indigestion and tobacco use among the conditions Kaitlin Kilian treats.

CMS data shows 144 Medicare services from Kaitlin Kilian across 3 procedure codes in 2024, all of them office visits, for 114 Medicare patients. Medicare paid $15,363 for them. Every service was in an office.

CMS counts 114 Medicare patients who saw Kaitlin Kilian in 2024. The largest group is 65 to 74, with 62 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 35% are also on Medicaid. Their average risk score is 2.13, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Kaitlin Kilian's median patient age at 63, with 51% women.

In 2024, Kaitlin Kilian wrote 283 Medicare Part D claims for 54 patients. 75% of them were for generic drugs. CMS names the drug for 215 of them, across 10 drugs with 11 or more claims each, at $109,291 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Kaitlin Kilian for performance year 2024, reported as part of a group. Kaitlin Kilian accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Kaitlin Kilian as offering telehealth.

CMS Open Payments shows 4 general payments to Kaitlin Kilian from 4 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Madrigal Pharmaceuticals paid the most, $99.